Non-hodgkin Lymphoma,B Cell Clinical Trials in Hangzhou, Zhejiang
4 recruitingHangzhou, Zhejiang, China
Showing 1–4 of 4 trials
Recruiting
Phase 1
The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma
Non-hodgkin Lymphoma,B Cell
Bioray Laboratories18 enrolled3 locationsNCT05741359
Recruiting
Early Phase 1
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research
Non-hodgkin Lymphoma,B Cell
Zhejiang University36 enrolled1 locationNCT06716164
Recruiting
Early Phase 1
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
Acute Lymphoblastic Leukemia,B-CellNon-hodgkin Lymphoma,B Cell
Zhejiang University20 enrolled1 locationNCT06346912
Recruiting
Early Phase 1
A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma,B Cell
Zhejiang University72 enrolled1 locationNCT04532268